These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 8676619

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.
    Leporrier M, Chevret S, Cazin B, Boudjerra N, Feugier P, Desablens B, Rapp MJ, Jaubert J, Autrand C, Divine M, Dreyfus B, Maloum K, Travade P, Dighiero G, Binet JL, Chastang C, French Cooperative Group on Chronic Lymphocytic Leukemia.
    Blood; 2001 Oct 15; 98(8):2319-25. PubMed ID: 11588025
    [Abstract] [Full Text] [Related]

  • 3. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar 15; 3(3):14. PubMed ID: 2484283
    [No Abstract] [Full Text] [Related]

  • 4. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
    Robertson LE, Keating MJ.
    Cancer Treat Res; 1993 Mar 15; 64():105-19. PubMed ID: 7680874
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Why do drugs work in CLL?
    Plunkett W, Begleiter A, Liliemark JO, Reed JC.
    Leuk Lymphoma; 1996 Oct 15; 22 Suppl 2():1-11. PubMed ID: 9021705
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
    Rodriguez G.
    Invest New Drugs; 1994 Oct 15; 12(2):75-92. PubMed ID: 7532163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of advanced chronic lymphocytic leukemia by fludarabine. Results of a clinical phase-II study.
    Hiddemann W, Rottmann R, Wörmann B, Thiel A, Essink M, Ottensmeier C, Freund M, Büchner T, van de Loo J.
    Ann Hematol; 1991 Jul 15; 63(1):1-4. PubMed ID: 1715191
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate.
    Coppo P, Scieux C, Ferchal F, Clauvel J, Lassoued K.
    Ann Hematol; 2000 Jan 15; 79(1):43-5. PubMed ID: 10663621
    [Abstract] [Full Text] [Related]

  • 20. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct 15; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.